OMVOH
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for OMVOH, covering 2023-10-26 to 2026-01-28. Get the full timeline:
Most recent: EMA Authorised: Omvoh (mirikizumab) — Eli Lilly Nederland B.V.
5 regulatory and trial events tracked for OMVOH, covering 2023-10-26 to 2026-01-28. Get the full timeline:
Most recent: EMA Authorised: Omvoh (mirikizumab) — Eli Lilly Nederland B.V.